chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Large (size of donut) red, hot to the touch, hard, swollen (4 days). Doctor almost had me come to urgent care.
Pt reported to ER and saw employee for a rash around small pox injection (jab) site.
Two hrs post immunization experienced generalized Pruritus. By 12 hr mark Pruritus decreased but now hard urticarial rash on forehead and mid back.
Right extremity neuralgia followed by right Bell's palsy 1 week later. 11/12/09 Medical records received for dates 10/7/09. DX: Bells palsy  c/o facial problems can't move rt. side face, unable to smile, wink, blink. OV10/17/09 DX: bells palsy, Lyme Disease test(+) x1 wk.  Pt. c/o rt. side face sore painful, jaw pain. Assessment: mild rt. side facial weakness.
Vomiting x 5-6 at 0100 12/18/09. At office small spitup. No signs of dehydration. Afebrile.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25Oct2021 as dose number unknown, single (Batch/Lot number: unknown), in right arm and on 31Dec2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 38 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Systemic Lupus" (unspecified if ongoing); "Rheumatoid Arthritis" (unspecified if ongoing); "Sjorgrens" (unspecified if ongoing); "IgA deficiency" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing); "ptsd" (unspecified if ongoing); "2 shoulder surgeries and 3 c sections" (unspecified if ongoing). No known allergies. Concomitant medication(s) included: AMLODIPINE, start date: 01Sep2010; PROPANOLOL [PROPRANOLOL], start date: 01Sep2010; LEVOTHYROXINE, start date: 01Sep2010; SERTRALINE, start date: 01Dec2016; PLAQUENIL [HYDROXYCHLOROQUINE PHOSPHATE], start date: 01Aug2017. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 24Jul2023, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (24Jul2023) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 from 24Jul2023 to 29Jul2023. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I am unsure of what brand of Hep B he received. Received hep b at medical center on 8/19 after birth. On approximated 9/24 he spiked a fever and we were sent to ER.
I had a fainting episode approximately 3 hours after receiving the Tdap shot. My arms went stone cold, and my chest felt tight, was dizzy, and my head shut down. I was taken home by my husband. I developed pain all over my body-muscles and joints, Taken to hospital by ambulance on 10/5/17. Pain in back, could not feel legs or move them or lift arms or sit up.
urine is now cloudy yellow; Black stoolS; opaque urine with black purple particulates and blotches of white particulates; This spontaneous case was reported by a consumer and describes the occurrence of FAECES DISCOLOURED (Black stoolS), URINE ABNORMALITY (opaque urine with black purple particulates and blotches of white particulates) and CHROMATURIA (urine is now cloudy yellow) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L02A) for COVID-19 vaccination.     Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.   On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 17-Feb-2021, the patient experienced FAECES DISCOLOURED (Black stoolS) and URINE ABNORMALITY (opaque urine with black purple particulates and blotches of white particulates). On 28-Feb-2021, the patient experienced CHROMATURIA (urine is now cloudy yellow). On 17-Feb-2021, FAECES DISCOLOURED (Black stoolS) had resolved. On 28-Feb-2021, URINE ABNORMALITY (opaque urine with black purple particulates and blotches of white particulates) had resolved. On 14-Mar-2021, CHROMATURIA (urine is now cloudy yellow) had resolved. Not Provided          No treatment medication was not reported  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-031222 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: no new information was updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-031222:Crosslinked
bigger patch - at the injection site; Hardness at the injection site; Itching at the injection site - itching a lot; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (bigger patch - at the injection site), VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site - itching a lot) and VACCINATION SITE PAIN (pain at the injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LORATADINE (CLARITIN), MAGNESIUM and GUAIFENESIN for an unknown indication.    On 07-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site - itching a lot) and VACCINATION SITE PAIN (pain at the injection site). On 16-Jan-2021, the patient experienced VACCINATION SITE REACTION (bigger patch - at the injection site). The patient was treated with CORTISONE for Vaccination site pruritus, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE REACTION (bigger patch - at the injection site), VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site - itching a lot) and VACCINATION SITE PAIN (pain at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient had a reaction to Neomycin containing vaccine.  Was given Varicella on 5/13/2008 and on 5/22/08 had a swollen thigh where only that vaccine had been given.  35 x 40 mm patch of erythema, papules, shallow induration of area. also very itchy.
erythema and swelling4cm x 4.5cm left upper arm, no systemic symptoms of infection,
This spontaneous report as received from a Medical assiostant referring to unspecified patients of unknown genders. No information regarding the patients' medical history, concurrent conditions or concomitant therapies was provided. On an unknown date, the patients were vaccinated with improperly stored dose of ROTATEQ Lot number reported as "M039434" with expiration date on 24-MAY-2018 (strength and route of administration were not reported) for prophylaxis, however no adverse effects reported.  It was reported that the vaccines were exposed to temperature of 22 grades F (Fahrenheit) for a time frame of 12 hours. There were no previous temperature excursions for vaccines.  The temperature excursion was recorded by a data logger. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1703USA006986: US-009507513-1703USA006985: US-009507513-1703USA006936: US-009507513-1703USA006983:
This case was reported by a healthcare professional (also the subject) and described the occurrence of numbness of upper and lower lips in a 23-year-old male subject who was vaccinated with ENGERIX B (GlaxoSmithKline). Concurrent medical conditions included possibly allergic to thimerosal. On an unspecified date in 1988 the subject received 1st dose of ENGERIX B (unknown, unknown arm). On an unspecified date, less than one month after vaccination with ENGERIX B, the subject experienced numbness of upper and lower lips. The event resolved after 24 to 48 hours. The healthcare professional did not assess this event to be serious. On an unspecified date in 1988, one month after 1st dose of ENGERIX B, the subject received 2nd dose of ENGERIX B (details unknown). On an unspecified date in 1988, at an unknown time after 2nd dose of ENGERIX B, the subject experienced a rush over his head of numbness, was presyncopal, was dizzy, had a hard time walking and had to crawl to other staff. The subject was monitored and released by the staff where he received the vaccination. He was not hospitalized overnight and no further treatment was recommended. The healthcare professional considered the events following 2nd dose of ENGERIX B as disabling. On an unspecified date, the events resolved. The vaccination series with ENGERIX B was discontinued. It was reported that the staff would not provide the subject the 3rd dose of ENGERIX B. The healthcare professional considered the events were probably related to vaccinations with ENGERIX B and stated that the events may have been related to the thimerosal in ENGERIX B at that time as he had a reaction to contact lens solution with thimerosal ingredient.
no adverse effect reported; Proquad experienced two temperature excursions; This spontaneous report was received from a registered nurse and refers to an 4-year-old patient of unknown gender. The patient's concurrent conditions, medical history, concomitant therapies, drug reactions and allergies were not reported.   On 27-AUG-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) lot # R026722, expiration date 17-MAR-2020 (dose, route of administration and anatomical location were not reported) or measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) lot # R023499, expiration date 13-FEB-2020 (dose, route of administration and anatomical location were not reported) for prophylaxis. Concomitant therapies included sterile diluent. Administered dose of vaccine experienced the temperature excursion from -14 degrees Celsius to -10 degrees Celcius for 8 hours. Data logger was involved. There were no previous excursions reported. There was no adverse effect reported.
Evening and two days following vaccination had rapid heartbeat, difficulty breathing , sweating, clammy, headache, nausea, body aches and chills,  and weeks later still experiencing some symptoms like difficulty breathing
The pt called on 11/1/02, complaining of a sore arm. Call returned by RN and she states her arm still sore and having difficulty raising arm to comb her hair. States she was at MD's office yesterday and the nurse looked at her arm and states it looked normal. The pt stated she did not want to go to MD and would call if arm not improved. Pt states arm still hurts but relieved with Tylenol.
A couple of hours after I received the Flu shot my ear had a very loud and severe tinnitus attack that lasted about a minute.  The severity lessened: however, that night it was loud and annoying enough to prevent sleep.  Since then it has become milder but it has not dissipated as of 10/11/*19 11:45 a.m.    I plan to get an appointment with and ENT since I have had chronic ear issues.   I could not find the exact match in the drop down list.   there was a date on the bottom on the information sheet 08/07/2015 Not sure what this is for.
The patient tells me that he had Covid in December, received his Covid vaccine yesterday and felt fine all day yesterday.  This morning he awoke with a fever and reportedly coughing a lot.  He reports the cough is productive of some phlegm.  No hemoptysis.  He describes it as moderate to severe.  Nothing specific seems to make it better.  He does report that he commonly has a cough but that worsened
mom reports became pale & limp >24hr p/vax;no fever or other side effect;s
GI Bleeding; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER -BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Lot number and expiration date was not reported) as DOSE 2, SINGLE, and via an unspecified route of administration on an unspecified date (Lot number and expiration date was not reported) as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient reported that patient had bleeding, a GI bleed afterwards, (reported as within a couple of months, afterwards got this bleeding, GI bleeding, a hemorrhage, it was terrible, as big as patient's hands and patient's hands coming out of clots). The patient was sent to a Hematologist and had to have blood transfusion. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
had almost like a tension headache, starts in back of neck and goes up and across the head.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunisation. Relevant medical history included: "Sleeping poorly" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: TENSION HEADACHE (non-serious) with onset Mar2021, outcome "unknown", described as "had almost like a tension headache, starts in back of neck and goes up and across the head.".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021351522 Same reporter, suspect drug and event; different patient
One week after first dose of vaccine I noticed a few red dots the size of a tiny pencil point on my left shin. the next day they were spreading and there were more of them. They were not raised and did not itch.  A few days later they spread to my right shin. Went to Dermatologist and his diagnosis was pigmented purpuric dermatosis, delayed dermal hypersensitivity reaction with lymphoctic vasculitis and finally trauma associated hemorrhage. no evidence of leukocytoclastic vasculitis is seen. Treatment use Triamcinolone Acetonide cream Usp 0.1% two times a day for a week. It has been two months and finally the dots are almost gone.
intense chills; This case was reported by a other health professional via interactive digital media and described the occurrence of chills in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced chills. On an unknown date, the outcome of the chills was unknown.   It was unknown if the reporter considered the chills to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication.  After receiving the dose of Shingrix the patient experienced intense chills later that evening while in bed. The patient inquired that does this suggest that patient should not receive second shot.
Patient had original Moderna vaccine on 20-Sep-2021, enquired if needed a 2nd or booster dose and was told 2nd dose of Moderna Covid vaccine is no longer available; No adverse event; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient had original Moderna vaccine on 20-Sep-2021, enquired if needed a 2nd or booster dose and was told 2nd dose of Moderna Covid vaccine is no longer available) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O4SC21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient had original Moderna vaccine on 20-Sep-2021, enquired if needed a 2nd or booster dose and was told 2nd dose of Moderna Covid vaccine is no longer available) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient had original Moderna vaccine on 20-Sep-2021, enquired if needed a 2nd or booster dose and was told 2nd dose of Moderna Covid vaccine is no longer available) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            No concomitant medications were reported.  Treatment information was not provided.
diarrhea Nausea pain in upper abdomen extreme fatigue chills  adverse event was over in 48 hrs
day of vaccination patient experienced generalized urticaria and extreme itching over entire body.  Self treated with Zyrtec. day 2 after vaccination - urticaria resolved and itching localized to vaccination site.   Diagnosed as probable hypersensitivity to a vaccine component.
I am 58 years old and in great health.  I am a property manager with great organizing skills and am able to stay on top of multiple tasks at the same time.  At the end of an event that I was in charge of, I returned home at approximately 11:30 pm, took a shower and went to my bedside where I was preparing to get into bed.  I felt a little 'out of body' when approaching the bed and upon arriving there, could not figure out how to move my extra pillows from the bed to the night stand where I have placed them every night for the past 12 years.  My wife asked me if I was Ok and I replied yes (later to find out that I was staring at my phone).  I climbed into bed and moments later my wife was sitting at my feed asking me what was wrong.  She said I lifted an extra pillow and asked what it was then threw it.  I was not aware of any of these actions.  She immediately googled 'mini stroke symptoms' and followed them.  I was very cognizant of her reading and repeated everything she asked me to repeat as well as participated in conversation normally but was till unaware of the pillow issue.  On 8/10/2021, I was talking with a trade that was doing work for us and he asked for my email.  I give my email out many times over the last 20 years.  When giving my email, I stated "jpeacewood.' and I could not figure out what was next.  I cognitively asked the trade to hold for a minute and tried to figure out what my email address is.  I picked up the phone about 30 seconds later and told him that I was distracted and continued..(unlisted email address) which is my address.    These are the only 2 issues I have had.  Again I am very healthy and this has never happened in my working career ever.  It is very concerning since I am hearing others having similar issues after receiving the vaccine for Covid.
Discharge Provider: DO Primary Care Provider at Discharge: PA-C Admission Date: 3/29/2023 Discharge Date: 3/31/2023  PRESENTING PROBLEM: Respiratory insufficiency [R06.89] COVID [U07.1] COVID-19 [U07.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE:    The patient is a 60 y.o. female with past medical history of chronic respiratory failure on 3 L oxygen at home, chronic obstructive pulmonary disease exacerbation/emphysema.  Patient recently discharged from other facility after being admitted and intubated due to respiratory failure, right lower lobe pneumonia and chronic obstructive pulmonary disease exacerbation.  Patient was intubated on 2/27, and extubated on 3/7, discharge on 03/11 with home health.   Patient presented to reporting hospital with positive home COVID tests.  Patient woke up in the morning around 3:00 a.m, 3/29. feeling fatigue with significant body aches.  She had significant subjective fevers and chills. Tmax 101 at home. Endorsed mild shortness of breath. Endorsed runny nose.  Endorsed nausea.  Denied vomiting, and abdominal pain, and dysuria.  No diarrhea.  Home oxygen was reported to be 81% on 3 L.    In the emergency department, oxygen is 94% on 2.5 L. Chest x-ray show emphysema no infiltrate.  Complete blood count show WBC of 3, hemoglobin 10. Chemistry panel is unremarkable.  Respiratory viral panel is positive for COVID-19 infection.   Patient was admitted in the hospital for monitoring.  She was placed on breathing treatment, Decadron and azithromycin for possible chronic obstructive pulmonary disease exacerbation.  She was stable on home oxygen therefore there was no indication for remdesivir.  The following day, patient was stable for discharge.  She was discharged on Paxilovid, Decadron, and was recommended for follow-up with primary care doctor.   Placed on gabapentin for chronic back pain.    Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge.
had patient sit was passing out called 911. Pt breathing normally observed patient until paramedics arrived.
Information has been received from a nurse practitioner concerning many patients that complain of pain after receiving GARDASIL. The nurse practitioner also reported that it "appears to be the most painful vaccination." Follow up information was received on 02-FEB-2009 from a nurse practitioner who stated that all the patients she has given GARDASIL too have complained that it was very painful, their arms went numb and felt heavy. The nurse practitioner felt this was why a lot of patients faint with the vaccine. The actual number of patients was not reported. This is one of several cases from the same source. Additional information is not expected.
rapid heart beat; muscle weakness like when you exercise a lot; ears ringing; felt weak; tachycardic; This is a spontaneous report from a contactable other healthcare professional (patient). A female patient (age: 55, Unit: Unknown) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date, as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced rapid heartbeat, muscle weakness like when you exercise a lot and ears ringing. She stated that almost three weeks after the vaccine she still had weakness and her heart rate goes up. It was reported 19 days post-dose 1, she felt weak and 20 days post-dose 1 she was feeling better - no longer weak/tachycardic. The outcome of events felt weak and tachycardic were resolved and unknown for rest of the events.  Information about lot and batch number was requested. One follow-up attempt are completed; information about batch/lot cannot be obtained.
PATIENT WITHIN 15 MINUTES OF INJECTION BEGAN TO HAVE TIGLING OF THE MOUTH. HE WAS THEN GIVEN 25MG OF BENADRIL AND ASK TO REMAIN IN THE WAITING AREA FOR HALF AN HOUR. HE THEN LEFT BECAUSE HE FELT BETTER.
On 2/1, 9 days post/vax, parent reported fine red rash & was referred to DR if not better in 2 days. On 2/4, parent called again & stated the rash was worse. On 2/8, pt had rash & T-100.4. Pt seen by DR. Dx;Non-contagious measles.
1st - Upper GI pain - similar to gastritis - pain scale 6/10.  Reduced to 2/10 in 4 hrs. 2nd - minor chills during 2-4 hours 3rd - muscle aches beginning at hour 4 - pain scale 3/10 - reduced to zero during sleep overnight